Intriguingly, depending on the relative HMGA2 expression levels in various cancer cell models, HMGA2 either triggered or attenuated the genotoxic action of the clinically important TOP1 poison irinotecan/SN38, specifically at heterochromatic subtelomeres (Ahmed et al., 2019). The gene discussed is HMGA2; the disease is cancer.